170 results
Keyword Sertraline Remove keyword
-
List item
Referral: Zoloft
sertraline, Article 30 referrals
Status: European Commission final decision, opinion/position date: 18/12/2008, EC decision date: 27/03/2009, Last updated: 07/05/2009contains the active substance sertraline. Sertraline is a selective serotonin … Serlain, Lustral, Tatig, Sertraline and Besitran. Why was Zoloft … containing 25 mg, 50 mg or 100 mg sertraline Concentrate for oral solution … -
List item
Referral: Serotonin-specific reuptake inhibitors and serotonin-noradrenaline reuptake inhibitors
atomoxetine, citalopram, escitalopram, fluoxetine, fluvoxamine, mianserine, milnacipran, mirtazapine, paroxetine, reboxetine, sertraline, venlafaxine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/04/2005, EC decision date: 19/08/2005, Last updated: 03/11/2005mirtazapine, paroxetine, reboxetine, sertraline and venlafaxine. The review … mirtazapine, paroxetine, reboxetine, sertraline and venlafaxine; clinical … mirtazapine, paroxetine, reboxetine, sertraline and venlafaxine containing … -
List item
Human medicine European public assessment report (EPAR): Thymanax
Agomelatine, Depressive Disorder, Major
Date of authorisation: 19/02/2009,
Date of refusal: 18/11/2006, Revision: 24, Authorised, Last updated: 08/08/2022study comparing Thymanax with sertraline (another antidepressant … Thymanax was more effective than sertraline, with a reduction in HAM D … study comparing Thymanax with sertraline (another antidepressant … -
List item
Human medicine European public assessment report (EPAR): Valdoxan
Agomelatine, Depressive Disorder, Major
Date of authorisation: 19/02/2009, Revision: 24, Authorised, Last updated: 08/08/2022study comparing Valdoxan with sertraline (another antidepressant … Valdoxan was more effective than sertraline, with a reduction in HAM D … study comparing Valdoxan with sertraline (another antidepressant … -
List item
National expert: Caroline Gjestad, Norwegian Medicines Agency (updated)
- Declaration of interests - 79.79 KB | PDF
- Curriculum Vitae - 17.94 KB | PDF
Citalopram, Escitalopram, and Sertraline; Therapeutic Drug Monitoring … -
List item
News: European Medicines Agency finalises review of antidepressants in children and adolescents
CHMP, Last updated: 25/04/2005mirtazapine, paroxetine, reboxetine, sertraline and venlafaxine. The review … paroxetine, reboxetine, sertraline and venlafaxine. 2. A previous … paroxetine, reboxetine, sertraline and venlafaxine; clinical … -
List item
National expert: Jogin Thakore, European Medicines Agency (updated)
- Declaration of interests - 83 KB | PDF
- Curriculum Vitae - 30.16 KB | PDF
open trial of adjunctive sertraline in the treatment of chronic schizophrenia … Schizophrenia 01/1995-12/2004 Pfizer Sertraline Depression 01/1999-07/2014 … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,15-18 December 2008
CHMP, Last updated: 18/12/2008and associated names (sertraline), from Pfizer group of companies … -
List item
Human medicine European public assessment report (EPAR): Stribild (updated)
elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate, HIV Infections
Date of authorisation: 24/05/2013, Revision: 25, Authorised, Last updated: 02/02/2023 -
List item
Human medicine European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Krka
efavirenz, emtricitabine, tenofovir disoproxil succinate, HIV Infections
Date of authorisation: 08/02/2018,
, Revision: 9, Authorised, Last updated: 05/12/2022
-
List item
National expert: Peter Schwartz, European Medicines Agency (updated)
- Declaration of interests - 81.12 KB | PDF
- Curriculum Vitae - 24 KB | PDF
ORal D-sotalol); SADHART (Sertraline AntiDepressant Heart Attack … -
List item
Human medicine European public assessment report (EPAR): Darunavir Krka
darunavir, HIV Infections
Date of authorisation: 26/01/2018,, Revision: 8, Authorised, Last updated: 23/11/2022
-
List item
Human medicine European public assessment report (EPAR): Darunavir Mylan
darunavir, HIV Infections
Date of authorisation: 03/01/2017,, Revision: 12, Authorised, Last updated: 04/11/2022
-
List item
Human medicine European public assessment report (EPAR): Striascan
ioflupane (123l), Radionuclide Imaging; Dementia; Movement Disorders
Date of authorisation: 25/06/2019,, Revision: 2, Authorised, Last updated: 05/12/2022
-
List item
Human medicine European public assessment report (EPAR): Suboxone (updated)
buprenorphine, naloxone, Opioid-Related Disorders
Date of authorisation: 26/09/2006, Revision: 21, Authorised, Last updated: 17/01/2023 -
List item
Human medicine European public assessment report (EPAR): Prezista
darunavir, HIV Infections
Date of authorisation: 11/02/2007, Revision: 54, Authorised, Last updated: 13/12/2022 -
List item
Human medicine European public assessment report (EPAR): Sustiva
efavirenz, HIV Infections
Date of authorisation: 28/05/1999, Revision: 46, Authorised, Last updated: 17/10/2022 -
List item
Human medicine European public assessment report (EPAR): Xermelo
telotristat etiprate, Carcinoid Tumor; Neuroendocrine Tumors
Date of authorisation: 17/09/2017,
, Revision: 15, Authorised, Last updated: 12/12/2022
-
List item
Human medicine European public assessment report (EPAR): Stocrin
efavirenz, HIV Infections
Date of authorisation: 28/05/1999, Revision: 47, Authorised, Last updated: 05/10/2022 -
List item
Human medicine European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan
efavirenz, emtricitabine, tenofovir disoproxil maleate, HIV Infections
Date of authorisation: 05/09/2017,, Revision: 13, Authorised, Last updated: 14/09/2022
-
List item
Human medicine European public assessment report (EPAR): Akynzeo
netupitant, palonosetron hydrochloride, Vomiting; Neoplasms; Nausea; Cancer
Date of authorisation: 27/05/2015, Revision: 14, Authorised, Last updated: 09/11/2022 -
List item
Human medicine European public assessment report (EPAR): Melatonin Neurim
melatonin, Sleep Initiation and Maintenance Disorders
Date of authorisation: 07/11/2022, Authorised, Last updated: 25/11/2022 -
List item
Human medicine European public assessment report (EPAR): Descovy
emtricitabine, tenofovir alafenamide, HIV Infections
Date of authorisation: 21/04/2016, Revision: 19, Authorised, Last updated: 14/11/2022 -
List item
Human medicine European public assessment report (EPAR): Norvir
ritonavir, HIV Infections
Date of authorisation: 25/08/1996, Revision: 68, Authorised, Last updated: 18/10/2022 -
List item
Human medicine European public assessment report (EPAR): Paxlovid (updated)
nirmatrelvir, ritonavir, COVID-19 virus infection
Date of authorisation: 28/01/2022,
, Revision: 8, Authorised, Last updated: 25/01/2023